Tag: life sciences
-
Chip Device Simulates Coronavirus Gut Symptoms
Biomedical engineers found a chip device with intestinal tissue can simulate coronavirus infections and symptoms in the gut, and test possible treatments.
-
Joint Venture to Develop Stable RNA Covid-19 Vaccine
A developer of synthetic bio-based products from engineered yeast cells is joining with an immunotherapy drug maker to produce a stable RNA Covid-19 vaccine.
-
Alphabet Forms AI Drug Discovery Company
Alphabet, the parent company of Google, is forming a new enterprise using artificial intelligence techniques to discover new protein-based drugs.
-
Cell Therapy Biotech Raises $75.5M in Venture Funds
A developer of off-the-shelf genetically engineered platelet cells to treat a range of diseases is raising $75.5 million in its second venture round.
-
Synthetic Protein Company Gains $25M in New Funds
A company designing engineered proteins to work better than natural chemistries as treatments for disease is raising $25 million in its first venture round.
-
Data Partnership Aims for Precise Parkinson’s Care
A medical device maker is offering brain stimulation data to a neurological software company to provide personalized care for people with Parkinson’s disease.
-
Hydrogel Obesity Capsule Shown to Protect Gut Tissue
Lab tests show an ingestible hydrogel designed to encourage weight loss by acting like raw vegetables helps protect and regulate intestinal tissue.
-
Stem Cell Patch Shown to Repair Retinal Damage
Research with lab rats shows a transplanted tissue patch derived from stem cells repairs damaged retinas and helps restore visual functions.
-
Biotech Gains $1M for Gut-Brain Pain Research
A biotechnology company developing treatments in the gut for mental health disorders is receiving a $1 million award for research on pain.
-
AI Analysis Finds Serious Covid-19 Genetic Driver
A deep and multi-variable analysis of patients with serious Covid-19 respiratory symptoms finds the condition associated with abnormal expression of one gene.